Karyopharm Therapeutics (KPTI) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.36
-0.33
-0.31
-0.28

Details

Expected EPS
-0.333857
Actual EPS
-0.32
Surprise EPS
0.01
Surprise Percent
+4.15%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -0.32 per share for Q2 2024.

0 Comments

Share your thoughts